Hepatitis Monthly

Published by: Kowsar

Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran

Hasan Afzali 1 , Mansooreh Momen-Heravi 2 , * and Asefeh Farokhzad 3
Authors Information
1 Associate Professor, Department of Infectious Disease, School of Medicine, Kashan University of Medical Sciences, Kashan, IR Iran
2 Associate Professor, Department of Infectious Disease, Social Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences, Kashan, IR Iran
3 Infectious Disease Specialist, Department of Infectious Disease, School of Medicine, Kashan University of Medical Sciences, Kashan, IR Iran
Article information
  • Hepatitis Monthly: July 2016, 16 (7); e30459
  • Published Online: June 5, 2016
  • Article Type: Research Article
  • Received: June 6, 2015
  • Revised: April 12, 2016
  • Accepted: May 28, 2016
  • DOI: 10.5812/hepatmon.30459

To Cite: Afzali H, Momen-Heravi M, Farokhzad A. Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran, Hepat Mon. 2016 ;16(7):e30459. doi: 10.5812/hepatmon.30459.

Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. De Cock KM, Jaffe HW, Curran JW. The evolving epidemiology of HIV/AIDS. AIDS. 2012; 26(10): 1205-13[DOI][PubMed]
  • 2. Olubajo B, Mitchell-Fearon K, Ogunmoroti O. A Comparative Systematic Review of the Optimal CD4 Cell Count Threshold for HIV Treatment Initiation. Interdiscip Perspect Infect Dis. 2014; 2014: 625670[DOI][PubMed]
  • 3. Clausen LN, Lundbo LF, Benfield T. Hepatitis C virus infection in the human immunodeficiency virus infected patient. World J Gastroenterol. 2014; 20(34): 12132-43[DOI][PubMed]
  • 4. Bennett JE, Dolin R, Blaser MJ. Principles and practice of infectious diseases. 2014;
  • 5. Pellicano R, Fagoonee S, Repici A, Rizzetto M. Hepatitis C virus and human immunodeficiency virus: a dangerous dealing. Panminerva Med. 2007; 49(2): 79-82[PubMed]
  • 6. Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012; 55 Suppl 1-42[DOI][PubMed]
  • 7. Grzeszczuk A, Wandalowicz AD, Jaroszewicz J, Flisiak R. Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland. Hepat Mon. 2015; 15(7)[DOI][PubMed]
  • 8. Andersson K, Chung RT. Hepatitis C Virus in the HIV-infected patient. Clin Liver Dis. 2006; 10(2): 303-20[DOI][PubMed]
  • 9. Tan YJ, Lim SG, Hong W. Understanding human immunodeficiency virus type 1 and hepatitis C virus coinfection. Curr HIV Res. 2006; 4(1): 21-30[PubMed]
  • 10. Bova C, Ogawa LF, Sullivan-Bolyai S. Hepatitis C treatment experiences and decision making among patients living with HIV infection. J Assoc Nurses AIDS Care. 2010; 21(1): 63-74[DOI][PubMed]
  • 11. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. Int J Infect Dis. 2010; 14(1)-33[DOI][PubMed]
  • 12. Davoodian P, Dadvand H, Mahoori K, Amoozandeh A, Salavati A. Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002. Braz J Infect Dis. 2009; 13(5): 356-8[DOI][PubMed]
  • 13. Zamani S, Radfar R, Nematollahi P, Fadaie R, Meshkati M, Mortazavi S, et al. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Int J Drug Policy. 2010; 21(6): 493-500[DOI][PubMed]
  • 14. Cachay ER, Peterson MR, Goicoechea M, Mathews WC. Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study. Br J Med Med Res. 2011; 1(4): 346-55[PubMed]
  • 15. Cotte L, Benet T, Billioud C, Miailhes P, Scoazec JY, Ferry T, et al. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. J Hepatol. 2011; 54(3): 489-96[DOI][PubMed]
  • 16. Bissonnette J, Genereux A, Cote J, Nguyen B, Perreault P, Bouchard L, et al. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension. J Gastroenterol Hepatol. 2012; 27(8): 1336-40[DOI][PubMed]
  • 17. Puoti M, Moioli MC, Travi G, Rossotti R. The burden of liver disease in human immunodeficiency virus-infected patients. Semin Liver Dis. 2012; 32(2): 103-13[DOI][PubMed]
  • 18. Demberg T, Robert-Guroff M. Controlling the HIV/AIDS epidemic: current status and global challenges. Front Immunol. 2012; 3: 250[DOI][PubMed]
  • 19. Alavian SM, Adibi P, Zali M. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005; 8(2): 84-90
  • 20. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res. 2007; 37(2): 101-3[DOI][PubMed]
  • 21. Khaja MN, Madhavi C, Thippavazzula R, Nafeesa F, Habib AM, Habibullah CM, et al. High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol. 2006; 6(3): 198-204[DOI][PubMed]
  • 22. Assarehzadegan M, Shakerinejad G, Norouzirad R, Amini A. Distribution of hepatitis C virus genotypes among patients with hepatitis C infection in Khuzestan province. Sci Med J .
  • 23. Badie BM, SeyedAlinaghi SA, Chaman R, Hosseini M, Hasibi M, Moharrami B, et al. Frequency and correlates of co-infection hepatitis c and hepatitis b with hiv.
  • 24. Kerubo G, Khamadi S, Okoth V, Madise N, Ezeh A, Abdalla Z, et al. Hepatitis B, hepatitis C and HIV-1 coinfection in two informal urban settlements in Nairobi, Kenya. PloS one. 2015; 10(6)
  • 25. Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC research notes. 2013; 6(1): 363
  • 26. Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004; 33(1): 182-8[DOI][PubMed]
  • 27. Quan VM, Go VF, Nam le V, Bergenstrom A, Thuoc NP, Zenilman J, et al. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. AIDS Care. 2009; 21(1): 7-16[DOI][PubMed]
  • 28. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med. 2007; 356(14): 1445-54[DOI][PubMed]
  • 29. Adewole OO, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P, et al. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries. 2009; 3(5): 369-75[PubMed]
  • 30. UNAIDS report on the global AIDS epidemic 2012;
  • 31. Report on the global AIDS epidemic 2008;
  • 32. Taeri K, Kasaeian N, Nobari RF, Ataei B. The prevalence of hepatitis B, hepatitis C and associated risk factors in intravenous drug addicts (IVDA) with HIV in Isfahan. J Isfahan Med Sch. 2008; 26(90)
  • 33. Vahdat K, Amini A, Motamed N, Eghbali SS, Zandi K, Hajiani G. Determination of Hepatit C genotype and risk factors of transmission in Bushehr province. 2008; 15(1): 51-8
  • 34. Khodabandehloo M, Roshani D. Prevalence of hepatitis C virus genotypes in Iranian patients: a systematic review and meta-analysis. Hepat mon. 2014; 14(12)
  • 35. Hadinedoushan H, Salmanroghani H, Amirbaigy MK, Akhondi-Meybodi M. Hepatitis C virus genotypes and association with viral load in yazd, central province of Iran. Hepat mon. 2014; 14(3)
  • 36. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol. 2004; 74(2): 246-52[DOI][PubMed]
  • 37. Moradi A, Semnani S, Keshtkar A, Khodabakhshi B, Kazeminejad V, Molana A, et al. Distribution of hepatitis C virus genotype among HCV infected patients in Golestan province, Iran. Govaresh. 2010; 15(1): 7-13
  • 38. Ahmadipour MH, Alavian SM, Amini S, Azadmanesh K. Hepatitis c virus genotypes. Hepat Mon. 2005; 5(3): 77-82
  • 39. Mohammadnejad E, Jalaimanesh S, Mahmoodi M. Clinical syndrome in HIV/AIDS resulting in hospitalization based on the CD4 count. J Mazandaran Univ Med Scie. 2010; 19(74): 70-7
  • 40. Korner C, Kramer B, Schulte D, Coenen M, Mauss S, Fatkenheuer G, et al. Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients. Clin Sci (Lond). 2009; 116(12): 861-70[DOI][PubMed]
  • 41. Ajayi EA, Ajayi AO, Adegun PT, Ajayi IA, Ojo AA, Raimi HT. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria. Pan African Med J. 2011; 9(1)
  • 42. Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. African Health Sci. 2013; 12(3): 312-7
  • 43. Kyrlagkitsis I, Portmann B, Smith H, O'Grady J, Cramp ME. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol. 2003; 98(7): 1588-93[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader